With generic weight-loss drugs set to arrive soon, marketers walk a tightrope between disease awareness and cosmetic allure ...

Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from top U.S. health officials at the FDA and ...

GLP-1 medications reduce appetite and overall food intake. Rapid weight loss can include loss of muscle mass if protein intake is too ...

Healthcare experts answer the most common questions about TrumpRx, plus who this new government portal is best for.

The Grand Rapids-based chain announced Tuesday it is making Wegovy and Ozempic more affordable to customers by accepting ...

Meijer said Tuesday it will accept manufacturer savings programs to reduce out-of-pocket costs for two widely used GLP-1 ...

The prevailing idea has been that a pill is easier to take, it's cheaper and it doesn't require refrigeration like Wegovy and Eli Lilly's (LLY) Zepbound injections. It's also been pitched as an ...

Novo Nordisk is suing telehealth company Hims and Hers, alleging patent infringement over a planned release of a knockoff version of its weight loss pill. Novo Nordisk, a Danish pharmaceutical company ...

The United Kingdom’s regulatory body for medicine and health-care products issued a warning for patients using semaglutide – ...

The company announced positive preclinical results from a study evaluating GDNF as a potential treatment for obesity and metabolic-associated steatotic liver disease.

Federal prescription drug platform TrumpRx aims to provide most-favored-nation pricing. Physicians discuss potential impact ...

The maker of Ozempic and Wegovy is suing a rival firm for selling what it says are "unsafe, knock-off" versions of its weight ...